← Back to Search

Behavioural Intervention

Refer2Quit for Smoking Cessation

N/A

Recruiting

Led By Brian P Jenssen, MD, MSHP

Research Sponsored by Children's Hospital of Philadelphia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adult Intervention Subject: Males or females ages ≥18 years in age, self-identify as a current combustible tobacco user, have a valid cell phone number

Be older than 18 years old

Must not have

Adult Intervention Subject: <18 years in age, indicates no combustible tobacco smoking

Adult Control Subject: <18 years in age, indicates no combustible tobacco smoking

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 and 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if a program called Refer2Quit can help household members who smoke to quit tobacco better than the usual treatment. They also want to understand what factors influence how well Refer2Quit

Who is the study for?

This trial is for household members who smoke and are interested in quitting. It's designed to see if a new approach, Refer2Quit, helps more people stop smoking compared to usual treatments. Specific characteristics of the participants and their families will also be studied.

What is being tested?

The study tests the Refer2Quit intervention against standard quit-smoking strategies. Participants will either receive this new method or continue with the typical support available, allowing researchers to compare success rates between the two groups.

What are the potential side effects?

Since this trial focuses on comparing different smoking cessation methods rather than testing a drug, it may not have direct side effects like medications do. However, quitting smoking can lead to withdrawal symptoms such as irritability, cravings, or difficulty concentrating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older, smoke tobacco, and have a cell phone.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am an adult and I do not smoke.

Select...

I am under 18 and do not smoke.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Combustible tobacco quit rate at 1 and 6 months

The proportion of adult participants who engage in any evidence-based tobacco use treatments

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention ArmExperimental Treatment1 Intervention

Adult intervention arm participants will receive motivational counseling provided by the study staff member enrolling them. The study team member will offer 4 evidence-based treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), emphasizing that the combination is often more effective than one treatment alone, and that they could start treatment even if they are not ready to quit.

Group II: Control ArmActive Control1 Intervention

Adult control arm participants will receive a handout listing tobacco treatment options that they can connect to on their own

0 / 3Eligibility criteria met